Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis

Journal of Immunology

Volumn 179, Issue 5, 2007, Pages 3315-3324

  Kawano, Akira ^a   Shimoda, Shinji ^a   Kamihira, Takashi ^a   Ishikawa, Fumihiko ^a,b   Niiro, Hiroaki ^c   Soejima, Yuji ^a   Taketomi, Akinobu ^a   Maehara, Yoshihiko ^a   Nakamura, Minoru ^d   Komori, Atsumasa ^d   Migita, Kiyoshi ^d   Ishibashi, Hiromi ^d   Azuma, Miyuki ^e   Gershwin, M Eric ^f   Harada, Mine ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; OGDC E2 PEPTIDE; PDC E2 PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; ACYLTRANSFERASE; AUTOANTIGEN; CYTOKINE; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE; ESCHERICHIA COLI PROTEIN; HLA DR ANTIGEN; HLA DR53; HLA-DR53; PEPTIDE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING SITE; CELL STIMULATION; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTING CELL; BILIARY CIRRHOSIS; CELL PROLIFERATION; CHEMISTRY; COCULTURE; DRUG EFFECT; FIBROBLAST; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ACYLTRANSFERASES; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; ANTIGENS, CD86; AUTOANTIGENS; CELL PROLIFERATION; CLONAL ANERGY; COCULTURE TECHNIQUES; CYTOKINES; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; ESCHERICHIA COLI PROTEINS; FIBROBLASTS; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; LIVER CIRRHOSIS, BILIARY; LYMPHOCYTE ACTIVATION; MICE; PEPTIDES; T-LYMPHOCYTES;

EID: 38449103813     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.5.3315     Document Type: Article

References (39)

1. Kaplan, M. M., and M. E. Gershwin. 2005. Primary biliary cirrhosis. N. Engl. J. Med. 353: 1261-1273.
2. + cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J. Exp. Med. 195: 113-123.
3. Kita, H., S. Matsumura, X. S. He, A. A. Ansari, Z. X. Lian, J. Van de Water, R. L. Coppel, M. M. Kaplan, and M. E. Gershwin. 2002. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J. Clin. Invest. 109: 1231-1240.
4. Shimoda, S., M. Nakamura, H. Ishibashi, K. Hayashida, and Y. Niho. 1995. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J. Exp. Med. 181: 1835-1845.
5. Shimoda, S., J. Van de Water, A. Ansari, M. Nakamura, H. Ishibashi, R. L. Coppel, J. Lake, E. B. Keeffe, T. E. Roche, and M. E. Gershwin. 1998. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J. Clin. Invest. 102: 1831-1840.
6. Selmi, C., and M. E. Gershwin. 2004. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr. Opin. Rheumatol. 16: 406-410.
7. Aoki, C. A., C. M. Roifman, Z. X. Lian, C. L. Bowlus, G. L. Norman, Y. Shoenfeld, I. R. Mackay, and M. E. Gershwin. 2006. IL-2 receptor α deficiency and features of primary biliary cirrhosis. J. Autoimmun. 27: 50-53.
8. Rieger, R., P. S. Leung, M. R. Jeddeloh, M. J. Kurth, M. H. Nantz, K. S. Lam, D. Barsky, A. A. Ansari, R. L. Coppel, I. R. Mackay, and M. E. Gershwin. 2006. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J. Autoimmun. 27: 7-16.
9. Amano, K., P. S. Leung, R. Rieger, C. Quan, X. Wang, J. Marik, Y. F. Suen, M. J. Kurth, M. H. Nantz, A. A. Ansari, et al. 2005. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J. Immunol. 174: 5874-5883.
10. Amano, K., P. S. Leung, Q. Xu, J. Marik, C. Quan, M. J. Kurth, M. H. Nantz, A. A. Ansari, K. S. Lam, M. Zeniya, R. L. Coppel, and M. E. Gershwin. 2004. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J. Immunol. 172: 6444-6452.
11. Long, S. A., C. Quan, J. Van de Water, M. H. Nantz, M. J. Kurth, D. Barsky, M. E. Colvin, K. S. Lam, R. L. Coppel, A. Ansari, and M. E. Gershwin. 2001. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J. Immunol. 167: 2956-2963.
12. Tanimoto, H., S. Shimoda, M. Nakamura, H. Ishibashi, A. Kawano, T. Kamihira, S. Matsushita, M. E. Gershwin, and M. Harada. 2003. Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis. J. Autoimmun. 20: 255-263.
13. 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 31: 1212-1216.
14. Gimmi, C. D., G. J. Freeman, J. G. Gribben, G. Gray, and L. M. Nadler. 1993. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA 90: 6586-6590.
15. Shimoda, S., F. Ishikawa, T. Kamihira, A. Komori, H. Niiro, E. Baba, K. Harada, K. Isse, Y. Nakanuma, H. Ishibashi, M. E. Gershwin, and M. Harada. 2006. Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory. Gastroenterology 131: 606-618.
16. Ausubel, L. J., J. I. Krieger, and D. A. Hafler. 1997. Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99. J. Immunol. 159: 2502-2512.
17. Kumar, V., V. Bhardwaj, L. Soares, J. Alexander, A. Sette, and E. Sercarz. 1995. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon γ by T cells. Proc. Natl. Acad. Sci. USA 92: 9510-9514.
18. Nicholson, L. B., J. M. Greer, R. A. Sobel, M. B. Lees, and V. K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3: 397-405.
19. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181: 1569-1574.
20. Murtaza, A., V. K. Kuchroo, and G. J. Freeman. 1999. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands. Int. Immunol. 11: 407-416.
21. Poussin, M. A., E. Tuzun, E. Goluszko, B. G. Scott, H. Yang, J. U. Franco, and P. Christadoss. 2003. B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis. J. Immunol. 170: 4389-4396.
22. Gao, J. X., H. Zhang, X. F. Bai, J. Wen, X. Zheng, J. Liu, P. Zheng, and Y. Liu. 2002. Perinatal blockade of B7-1 and B7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells. J. Exp. Med. 195: 959-971.
23. Reynolds, J., F. W. Tam, A. Chandraker, J. Smith, A. M. Karkar, J. Cross, R. Peach, M. H. Sayegh, and C. D. Pusey. 2000. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J. Clin. Invest. 105: 643-651.
24. 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens. Hepatology 32: 901-909.
25. Madrenas, J., R. H. Schwartz, and R. N. Germain. 1996. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists. Proc. Natl. Acad. Sci. USA 93: 9736-9741.
26. Kamihira, T., S. Shimoda, K. Harada, A. Kawano, M. Handa, E. Baba, K. Tsuneyama, M. Nakamura, H. Ishibashi, Y. Nakanuma, M. E. Gershwin, and M. Harada. 2003. Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology 125: 1379-1387.
27. Chen, Y. Z., S. Matsushita, and Y. Nishimura. 1996. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation. J. Immunol. 157: 3783-3790.
28. Allen, P. M. 1994. Peptides in positive and negative selection: a delicate balance. Cell 76: 593-596.
29. Goldrath, A. W., and M. J. Bevan. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature 402: 255-262.
30. Jameson, S. C., and M. J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity 2: 1-11.
31. Sette, A., J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H. M. Grey. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12: 413-431.
32. + T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues. Cancer Res. 63: 1560-1567.
33. Kamihira, T., S. Shimoda, M. Nakamura, T. Yokoyama, Y. Takii, A. Kawano, M. Handa, H. Ishibashi, M. E. Gershwin, and M. Harada. 2005. Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases. Hepatology 41: 151-159.
34. Kaji, K., K. Tsuneyama, Y. Nakanuma, K. Harada, M. Sasaki, S. Kaneko, and K. Kobayashi. 1997. B7-2 positive cells around interlobular bile ducts in primary biliary cirrhosis and chronic hepatitis C. J. Gastroenterol. Hepatol. 12: 507-512.
35. Spengler, U., L. Leifeld, I. Braunschweiger, F. L. Dumoulin, M. Lechmann, and T. Sauerbruch. 1997. Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. J. Hepatol. 26: 31-36.
36. Tsuneyama, K., K. Harada, M. Yasoshima, K. Kaji, M. E. Gershwin, and Y. Nakanuma. 1998. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study. J. Pathol. 186: 126-130.
37. Iwata, M., K. Harada, K. Hiramatsu, K. Tsuneyama, S. Kaneko, K. Kobayashi, and Y. Nakanuma. 2000. Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis. Liver 20: 129-135.
38. Bjorkland, A., L. Loof, I. Mendel-Hartvig, and T. H. Totterman. 1994. Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes. J. Immunol. 153: 2750-2757.
39. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175: 353-360.